nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—CA5B—Lacosamide—epilepsy syndrome	0.111	0.148	CbGbCtD
Dobutamine—CA5A—Acetazolamide—epilepsy syndrome	0.0873	0.117	CbGbCtD
Dobutamine—CA5A—Zonisamide—epilepsy syndrome	0.0807	0.108	CbGbCtD
Dobutamine—CA2—Lacosamide—epilepsy syndrome	0.0767	0.102	CbGbCtD
Dobutamine—CA5B—Acetazolamide—epilepsy syndrome	0.076	0.102	CbGbCtD
Dobutamine—CA5B—Zonisamide—epilepsy syndrome	0.0704	0.094	CbGbCtD
Dobutamine—CA5A—Topiramate—epilepsy syndrome	0.0588	0.0786	CbGbCtD
Dobutamine—CA2—Acetazolamide—epilepsy syndrome	0.0528	0.0705	CbGbCtD
Dobutamine—CA5B—Topiramate—epilepsy syndrome	0.0513	0.0685	CbGbCtD
Dobutamine—CA2—Zonisamide—epilepsy syndrome	0.0488	0.0652	CbGbCtD
Dobutamine—CA2—Topiramate—epilepsy syndrome	0.0356	0.0475	CbGbCtD
Dobutamine—Skin necrosis—Midazolam—epilepsy syndrome	0.00448	0.0428	CcSEcCtD
Dobutamine—COMT—telencephalic ventricle—epilepsy syndrome	0.00377	0.152	CbGeAlD
Dobutamine—Skin necrosis—Pregabalin—epilepsy syndrome	0.00246	0.0235	CcSEcCtD
Dobutamine—COMT—ganglion—epilepsy syndrome	0.00235	0.0947	CbGeAlD
Dobutamine—Skin necrosis—Gabapentin—epilepsy syndrome	0.00226	0.0216	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Propofol—epilepsy syndrome	0.00177	0.0169	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Midazolam—epilepsy syndrome	0.00173	0.0166	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Fosphenytoin—epilepsy syndrome	0.00165	0.0158	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Zonisamide—epilepsy syndrome	0.0015	0.0143	CcSEcCtD
Dobutamine—Skin exfoliation—Midazolam—epilepsy syndrome	0.00149	0.0143	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Phenytoin—epilepsy syndrome	0.00144	0.0137	CcSEcCtD
Dobutamine—Phlebitis—Propofol—epilepsy syndrome	0.00135	0.0129	CcSEcCtD
Dobutamine—Phlebitis—Midazolam—epilepsy syndrome	0.00132	0.0126	CcSEcCtD
Dobutamine—Phlebitis—Diazepam—epilepsy syndrome	0.00121	0.0115	CcSEcCtD
Dobutamine—Hypokalaemia—Acetazolamide—epilepsy syndrome	0.00114	0.0109	CcSEcCtD
Dobutamine—CA2—hindbrain—epilepsy syndrome	0.00111	0.0446	CbGeAlD
Dobutamine—COMT—brainstem—epilepsy syndrome	0.00102	0.0412	CbGeAlD
Dobutamine—Hypokalaemia—Fosphenytoin—epilepsy syndrome	0.000985	0.00941	CcSEcCtD
Dobutamine—COMT—forebrain—epilepsy syndrome	0.000985	0.0397	CbGeAlD
Dobutamine—Hypotension—Amobarbital—epilepsy syndrome	0.000959	0.00916	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Pregabalin—epilepsy syndrome	0.000953	0.0091	CcSEcCtD
Dobutamine—Hypokalaemia—Felbamate—epilepsy syndrome	0.000915	0.00874	CcSEcCtD
Dobutamine—COMT—telencephalon—epilepsy syndrome	0.000906	0.0365	CbGeAlD
Dobutamine—Hypokalaemia—Zonisamide—epilepsy syndrome	0.000896	0.00856	CcSEcCtD
Dobutamine—Ventricular extrasystoles—Gabapentin—epilepsy syndrome	0.000873	0.00834	CcSEcCtD
Dobutamine—Hypokalaemia—Phenytoin—epilepsy syndrome	0.000858	0.00819	CcSEcCtD
Dobutamine—Hypokalaemia—Oxcarbazepine—epilepsy syndrome	0.000853	0.00815	CcSEcCtD
Dobutamine—Thrombocytopenia—Trimethadione—epilepsy syndrome	0.000852	0.00814	CcSEcCtD
Dobutamine—ADRB1—forebrain—epilepsy syndrome	0.000834	0.0337	CbGeAlD
Dobutamine—Skin exfoliation—Pregabalin—epilepsy syndrome	0.000821	0.00785	CcSEcCtD
Dobutamine—Hypokalaemia—Carbamazepine—epilepsy syndrome	0.000819	0.00782	CcSEcCtD
Dobutamine—Palpitations—Lacosamide—epilepsy syndrome	0.000769	0.00735	CcSEcCtD
Dobutamine—ADRB1—telencephalon—epilepsy syndrome	0.000767	0.031	CbGeAlD
Dobutamine—Skin exfoliation—Gabapentin—epilepsy syndrome	0.000753	0.00719	CcSEcCtD
Dobutamine—Chest pain—Lacosamide—epilepsy syndrome	0.000741	0.00708	CcSEcCtD
Dobutamine—Thrombocytopenia—Rufinamide—epilepsy syndrome	0.000741	0.00707	CcSEcCtD
Dobutamine—Angina pectoris—Lamotrigine—epilepsy syndrome	0.000732	0.00699	CcSEcCtD
Dobutamine—Phlebitis—Pregabalin—epilepsy syndrome	0.000725	0.00692	CcSEcCtD
Dobutamine—Hypotension—Phenobarbital—epilepsy syndrome	0.00072	0.00688	CcSEcCtD
Dobutamine—COMT—medulla oblongata—epilepsy syndrome	0.000712	0.0287	CbGeAlD
Dobutamine—Thrombocytopenia—Clobazam—epilepsy syndrome	0.000675	0.00645	CcSEcCtD
Dobutamine—Phlebitis—Gabapentin—epilepsy syndrome	0.000665	0.00635	CcSEcCtD
Dobutamine—COMT—midbrain—epilepsy syndrome	0.00065	0.0262	CbGeAlD
Dobutamine—Hypotension—Clobazam—epilepsy syndrome	0.000644	0.00615	CcSEcCtD
Dobutamine—Headache—Amobarbital—epilepsy syndrome	0.000643	0.00614	CcSEcCtD
Dobutamine—COMT—spinal cord—epilepsy syndrome	0.000635	0.0256	CbGeAlD
Dobutamine—CA2—brainstem—epilepsy syndrome	0.000634	0.0256	CbGeAlD
Dobutamine—Headache—Primidone—epilepsy syndrome	0.00062	0.00592	CcSEcCtD
Dobutamine—Pruritus—Trimethadione—epilepsy syndrome	0.000616	0.00588	CcSEcCtD
Dobutamine—CA5B—head—epilepsy syndrome	0.000612	0.0247	CbGeAlD
Dobutamine—CA2—forebrain—epilepsy syndrome	0.000612	0.0247	CbGeAlD
Dobutamine—Nausea—Amobarbital—epilepsy syndrome	0.00061	0.00583	CcSEcCtD
Dobutamine—Thrombocytopenia—Acetazolamide—epilepsy syndrome	0.000602	0.00575	CcSEcCtD
Dobutamine—Chest pain—Propofol—epilepsy syndrome	0.000595	0.00569	CcSEcCtD
Dobutamine—Nausea—Primidone—epilepsy syndrome	0.000588	0.00561	CcSEcCtD
Dobutamine—CA5B—nervous system—epilepsy syndrome	0.00058	0.0234	CbGeAlD
Dobutamine—Palpitations—Fosphenytoin—epilepsy syndrome	0.000576	0.0055	CcSEcCtD
Dobutamine—Chest pain—Levetiracetam—epilepsy syndrome	0.000575	0.00549	CcSEcCtD
Dobutamine—Hypokalaemia—Pregabalin—epilepsy syndrome	0.000568	0.00543	CcSEcCtD
Dobutamine—COMT—head—epilepsy syndrome	0.000564	0.0228	CbGeAlD
Dobutamine—CA2—telencephalon—epilepsy syndrome	0.000563	0.0227	CbGeAlD
Dobutamine—Phlebitis—Topiramate—epilepsy syndrome	0.000559	0.00534	CcSEcCtD
Dobutamine—CA5B—central nervous system—epilepsy syndrome	0.000559	0.0226	CbGeAlD
Dobutamine—Tachycardia—Propofol—epilepsy syndrome	0.000557	0.00532	CcSEcCtD
Dobutamine—Palpitations—Diazepam—epilepsy syndrome	0.000553	0.00528	CcSEcCtD
Dobutamine—Headache—Trimethadione—epilepsy syndrome	0.000545	0.00521	CcSEcCtD
Dobutamine—Tachycardia—Midazolam—epilepsy syndrome	0.000545	0.00521	CcSEcCtD
Dobutamine—Chest pain—Vigabatrin—epilepsy syndrome	0.000541	0.00517	CcSEcCtD
Dobutamine—Thrombocytopenia—Levetiracetam—epilepsy syndrome	0.00054	0.00516	CcSEcCtD
Dobutamine—Palpitations—Felbamate—epilepsy syndrome	0.000535	0.00511	CcSEcCtD
Dobutamine—Pruritus—Rufinamide—epilepsy syndrome	0.000535	0.00511	CcSEcCtD
Dobutamine—COMT—nervous system—epilepsy syndrome	0.000535	0.0216	CbGeAlD
Dobutamine—Hypotension—Propofol—epilepsy syndrome	0.000533	0.00509	CcSEcCtD
Dobutamine—Angina pectoris—Pregabalin—epilepsy syndrome	0.000526	0.00502	CcSEcCtD
Dobutamine—Palpitations—Zonisamide—epilepsy syndrome	0.000524	0.005	CcSEcCtD
Dobutamine—Hypotension—Midazolam—epilepsy syndrome	0.000522	0.00498	CcSEcCtD
Dobutamine—Thrombocytopenia—Fosphenytoin—epilepsy syndrome	0.000521	0.00498	CcSEcCtD
Dobutamine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000519	0.00496	CcSEcCtD
Dobutamine—Nausea—Trimethadione—epilepsy syndrome	0.000517	0.00494	CcSEcCtD
Dobutamine—Chest pain—Felbamate—epilepsy syndrome	0.000516	0.00493	CcSEcCtD
Dobutamine—COMT—central nervous system—epilepsy syndrome	0.000515	0.0208	CbGeAlD
Dobutamine—Dyspnoea—Propofol—epilepsy syndrome	0.000509	0.00486	CcSEcCtD
Dobutamine—Palpitations—Clonazepam—epilepsy syndrome	0.000505	0.00482	CcSEcCtD
Dobutamine—Chest pain—Zonisamide—epilepsy syndrome	0.000505	0.00482	CcSEcCtD
Dobutamine—COMT—cerebellum—epilepsy syndrome	0.000503	0.0203	CbGeAlD
Dobutamine—Pruritus—Lacosamide—epilepsy syndrome	0.000503	0.0048	CcSEcCtD
Dobutamine—Palpitations—Phenytoin—epilepsy syndrome	0.000502	0.00479	CcSEcCtD
Dobutamine—Thrombocytopenia—Diazepam—epilepsy syndrome	0.0005	0.00478	CcSEcCtD
Dobutamine—Palpitations—Oxcarbazepine—epilepsy syndrome	0.000499	0.00477	CcSEcCtD
Dobutamine—Tachycardia—Diazepam—epilepsy syndrome	0.000498	0.00476	CcSEcCtD
Dobutamine—Dyspnoea—Midazolam—epilepsy syndrome	0.000498	0.00476	CcSEcCtD
Dobutamine—Hypotension—Fosphenytoin—epilepsy syndrome	0.000497	0.00475	CcSEcCtD
Dobutamine—Pruritus—Clobazam—epilepsy syndrome	0.000488	0.00466	CcSEcCtD
Dobutamine—Chest pain—Clonazepam—epilepsy syndrome	0.000486	0.00465	CcSEcCtD
Dobutamine—Thrombocytopenia—Felbamate—epilepsy syndrome	0.000484	0.00462	CcSEcCtD
Dobutamine—Chest pain—Phenytoin—epilepsy syndrome	0.000483	0.00462	CcSEcCtD
Dobutamine—Headache—Phenobarbital—epilepsy syndrome	0.000483	0.00461	CcSEcCtD
Dobutamine—Tachycardia—Felbamate—epilepsy syndrome	0.000482	0.00461	CcSEcCtD
Dobutamine—Angina pectoris—Gabapentin—epilepsy syndrome	0.000482	0.00461	CcSEcCtD
Dobutamine—Chest pain—Oxcarbazepine—epilepsy syndrome	0.000481	0.00459	CcSEcCtD
Dobutamine—ADRB1—head—epilepsy syndrome	0.000478	0.0193	CbGeAlD
Dobutamine—Hypotension—Diazepam—epilepsy syndrome	0.000477	0.00456	CcSEcCtD
Dobutamine—Dyspnoea—Fosphenytoin—epilepsy syndrome	0.000474	0.00453	CcSEcCtD
Dobutamine—Headache—Rufinamide—epilepsy syndrome	0.000474	0.00453	CcSEcCtD
Dobutamine—Thrombocytopenia—Zonisamide—epilepsy syndrome	0.000474	0.00452	CcSEcCtD
Dobutamine—Tachycardia—Zonisamide—epilepsy syndrome	0.000472	0.00451	CcSEcCtD
Dobutamine—Palpitations—Lamotrigine—epilepsy syndrome	0.000463	0.00442	CcSEcCtD
Dobutamine—Hypotension—Felbamate—epilepsy syndrome	0.000462	0.00441	CcSEcCtD
Dobutamine—Chest pain—Carbamazepine—epilepsy syndrome	0.000461	0.00441	CcSEcCtD
Dobutamine—Nausea—Phenobarbital—epilepsy syndrome	0.000458	0.00437	CcSEcCtD
Dobutamine—Thrombocytopenia—Clonazepam—epilepsy syndrome	0.000457	0.00436	CcSEcCtD
Dobutamine—Dyspnoea—Diazepam—epilepsy syndrome	0.000455	0.00435	CcSEcCtD
Dobutamine—Tachycardia—Clonazepam—epilepsy syndrome	0.000455	0.00435	CcSEcCtD
Dobutamine—Thrombocytopenia—Phenytoin—epilepsy syndrome	0.000453	0.00433	CcSEcCtD
Dobutamine—ADRB1—nervous system—epilepsy syndrome	0.000453	0.0183	CbGeAlD
Dobutamine—Hypotension—Zonisamide—epilepsy syndrome	0.000452	0.00432	CcSEcCtD
Dobutamine—Tachycardia—Phenytoin—epilepsy syndrome	0.000452	0.00432	CcSEcCtD
Dobutamine—Thrombocytopenia—Oxcarbazepine—epilepsy syndrome	0.000451	0.00431	CcSEcCtD
Dobutamine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.00045	0.0043	CcSEcCtD
Dobutamine—Nausea—Rufinamide—epilepsy syndrome	0.000449	0.00429	CcSEcCtD
Dobutamine—Chest pain—Lamotrigine—epilepsy syndrome	0.000446	0.00426	CcSEcCtD
Dobutamine—Headache—Lacosamide—epilepsy syndrome	0.000445	0.00425	CcSEcCtD
Dobutamine—CA5B—brain—epilepsy syndrome	0.000444	0.0179	CbGeAlD
Dobutamine—CA2—medulla oblongata—epilepsy syndrome	0.000442	0.0178	CbGeAlD
Dobutamine—Dyspnoea—Felbamate—epilepsy syndrome	0.000441	0.00421	CcSEcCtD
Dobutamine—Hypokalaemia—Topiramate—epilepsy syndrome	0.000438	0.00419	CcSEcCtD
Dobutamine—ADRB1—central nervous system—epilepsy syndrome	0.000436	0.0176	CbGeAlD
Dobutamine—Hypotension—Clonazepam—epilepsy syndrome	0.000436	0.00416	CcSEcCtD
Dobutamine—Thrombocytopenia—Carbamazepine—epilepsy syndrome	0.000433	0.00413	CcSEcCtD
Dobutamine—Hypotension—Phenytoin—epilepsy syndrome	0.000433	0.00413	CcSEcCtD
Dobutamine—Headache—Clobazam—epilepsy syndrome	0.000432	0.00413	CcSEcCtD
Dobutamine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000431	0.00412	CcSEcCtD
Dobutamine—Dyspnoea—Zonisamide—epilepsy syndrome	0.000431	0.00412	CcSEcCtD
Dobutamine—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000431	0.00411	CcSEcCtD
Dobutamine—Nausea—Lacosamide—epilepsy syndrome	0.000422	0.00403	CcSEcCtD
Dobutamine—Thrombocytopenia—Lamotrigine—epilepsy syndrome	0.000418	0.004	CcSEcCtD
Dobutamine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000417	0.00398	CcSEcCtD
Dobutamine—Dyspnoea—Clonazepam—epilepsy syndrome	0.000416	0.00397	CcSEcCtD
Dobutamine—Hypotension—Carbamazepine—epilepsy syndrome	0.000413	0.00395	CcSEcCtD
Dobutamine—Dyspnoea—Phenytoin—epilepsy syndrome	0.000413	0.00394	CcSEcCtD
Dobutamine—Formoterol—CYP2C19—epilepsy syndrome	0.000412	0.165	CrCbGaD
Dobutamine—Arformoterol—CYP2C19—epilepsy syndrome	0.000412	0.165	CrCbGaD
Dobutamine—Dyspnoea—Oxcarbazepine—epilepsy syndrome	0.000411	0.00392	CcSEcCtD
Dobutamine—Nausea—Clobazam—epilepsy syndrome	0.000409	0.00391	CcSEcCtD
Dobutamine—COMT—brain—epilepsy syndrome	0.000409	0.0165	CbGeAlD
Dobutamine—Angina pectoris—Topiramate—epilepsy syndrome	0.000406	0.00387	CcSEcCtD
Dobutamine—CA2—midbrain—epilepsy syndrome	0.000404	0.0163	CbGeAlD
Dobutamine—Pruritus—Propofol—epilepsy syndrome	0.000404	0.00386	CcSEcCtD
Dobutamine—Pruritus—Midazolam—epilepsy syndrome	0.000395	0.00377	CcSEcCtD
Dobutamine—CA2—spinal cord—epilepsy syndrome	0.000394	0.0159	CbGeAlD
Dobutamine—Dyspnoea—Carbamazepine—epilepsy syndrome	0.000394	0.00377	CcSEcCtD
Dobutamine—Pruritus—Levetiracetam—epilepsy syndrome	0.00039	0.00373	CcSEcCtD
Dobutamine—Headache—Acetazolamide—epilepsy syndrome	0.000385	0.00368	CcSEcCtD
Dobutamine—Dyspnoea—Lamotrigine—epilepsy syndrome	0.000381	0.00364	CcSEcCtD
Dobutamine—Pruritus—Fosphenytoin—epilepsy syndrome	0.000377	0.0036	CcSEcCtD
Dobutamine—Palpitations—Valproic Acid—epilepsy syndrome	0.000368	0.00351	CcSEcCtD
Dobutamine—Pruritus—Vigabatrin—epilepsy syndrome	0.000367	0.00351	CcSEcCtD
Dobutamine—Nausea—Acetazolamide—epilepsy syndrome	0.000365	0.00349	CcSEcCtD
Dobutamine—Pruritus—Diazepam—epilepsy syndrome	0.000361	0.00345	CcSEcCtD
Dobutamine—Headache—Propofol—epilepsy syndrome	0.000358	0.00342	CcSEcCtD
Dobutamine—Chest pain—Valproic Acid—epilepsy syndrome	0.000354	0.00338	CcSEcCtD
Dobutamine—CA2—head—epilepsy syndrome	0.00035	0.0141	CbGeAlD
Dobutamine—Headache—Midazolam—epilepsy syndrome	0.00035	0.00334	CcSEcCtD
Dobutamine—Pruritus—Felbamate—epilepsy syndrome	0.00035	0.00334	CcSEcCtD
Dobutamine—ADRB1—brain—epilepsy syndrome	0.000346	0.014	CbGeAlD
Dobutamine—Headache—Levetiracetam—epilepsy syndrome	0.000345	0.0033	CcSEcCtD
Dobutamine—Pruritus—Zonisamide—epilepsy syndrome	0.000342	0.00327	CcSEcCtD
Dobutamine—Nausea—Propofol—epilepsy syndrome	0.000339	0.00324	CcSEcCtD
Dobutamine—Headache—Fosphenytoin—epilepsy syndrome	0.000333	0.00318	CcSEcCtD
Dobutamine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.000332	0.00318	CcSEcCtD
Dobutamine—Palpitations—Pregabalin—epilepsy syndrome	0.000332	0.00317	CcSEcCtD
Dobutamine—CA2—nervous system—epilepsy syndrome	0.000332	0.0134	CbGeAlD
Dobutamine—Nausea—Midazolam—epilepsy syndrome	0.000332	0.00317	CcSEcCtD
Dobutamine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000331	0.00317	CcSEcCtD
Dobutamine—Pruritus—Clonazepam—epilepsy syndrome	0.00033	0.00315	CcSEcCtD
Dobutamine—Pruritus—Phenytoin—epilepsy syndrome	0.000328	0.00313	CcSEcCtD
Dobutamine—Nausea—Levetiracetam—epilepsy syndrome	0.000328	0.00313	CcSEcCtD
Dobutamine—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000326	0.00311	CcSEcCtD
Dobutamine—Headache—Vigabatrin—epilepsy syndrome	0.000325	0.0031	CcSEcCtD
Dobutamine—Chest pain—Pregabalin—epilepsy syndrome	0.00032	0.00306	CcSEcCtD
Dobutamine—Headache—Diazepam—epilepsy syndrome	0.00032	0.00306	CcSEcCtD
Dobutamine—CA2—central nervous system—epilepsy syndrome	0.00032	0.0129	CbGeAlD
Dobutamine—Hypotension—Valproic Acid—epilepsy syndrome	0.000317	0.00303	CcSEcCtD
Dobutamine—Nausea—Fosphenytoin—epilepsy syndrome	0.000316	0.00302	CcSEcCtD
Dobutamine—Pruritus—Carbamazepine—epilepsy syndrome	0.000313	0.00299	CcSEcCtD
Dobutamine—CA2—cerebellum—epilepsy syndrome	0.000313	0.0126	CbGeAlD
Dobutamine—Headache—Felbamate—epilepsy syndrome	0.00031	0.00296	CcSEcCtD
Dobutamine—Nausea—Vigabatrin—epilepsy syndrome	0.000308	0.00294	CcSEcCtD
Dobutamine—Dopamine—HTR7—epilepsy syndrome	0.000308	0.123	CrCbGaD
Dobutamine—Formoterol—CYP2D6—epilepsy syndrome	0.000306	0.122	CrCbGaD
Dobutamine—Arformoterol—CYP2D6—epilepsy syndrome	0.000306	0.122	CrCbGaD
Dobutamine—Palpitations—Gabapentin—epilepsy syndrome	0.000305	0.00291	CcSEcCtD
Dobutamine—Nausea—Diazepam—epilepsy syndrome	0.000303	0.0029	CcSEcCtD
Dobutamine—Headache—Zonisamide—epilepsy syndrome	0.000303	0.0029	CcSEcCtD
Dobutamine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000303	0.00289	CcSEcCtD
Dobutamine—Pruritus—Lamotrigine—epilepsy syndrome	0.000302	0.00289	CcSEcCtD
Dobutamine—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000301	0.00287	CcSEcCtD
Dobutamine—Tachycardia—Pregabalin—epilepsy syndrome	0.0003	0.00286	CcSEcCtD
Dobutamine—Chest pain—Gabapentin—epilepsy syndrome	0.000294	0.0028	CcSEcCtD
Dobutamine—Nausea—Felbamate—epilepsy syndrome	0.000294	0.0028	CcSEcCtD
Dobutamine—Headache—Clonazepam—epilepsy syndrome	0.000292	0.00279	CcSEcCtD
Dobutamine—Headache—Phenytoin—epilepsy syndrome	0.00029	0.00277	CcSEcCtD
Dobutamine—Headache—Oxcarbazepine—epilepsy syndrome	0.000289	0.00276	CcSEcCtD
Dobutamine—Nausea—Zonisamide—epilepsy syndrome	0.000287	0.00275	CcSEcCtD
Dobutamine—Hypotension—Pregabalin—epilepsy syndrome	0.000287	0.00274	CcSEcCtD
Dobutamine—Nausea—Clonazepam—epilepsy syndrome	0.000277	0.00265	CcSEcCtD
Dobutamine—Headache—Carbamazepine—epilepsy syndrome	0.000277	0.00265	CcSEcCtD
Dobutamine—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000276	0.00263	CcSEcCtD
Dobutamine—Nausea—Phenytoin—epilepsy syndrome	0.000275	0.00263	CcSEcCtD
Dobutamine—Tachycardia—Gabapentin—epilepsy syndrome	0.000275	0.00262	CcSEcCtD
Dobutamine—Dyspnoea—Pregabalin—epilepsy syndrome	0.000274	0.00261	CcSEcCtD
Dobutamine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000274	0.00261	CcSEcCtD
Dobutamine—Headache—Lamotrigine—epilepsy syndrome	0.000268	0.00256	CcSEcCtD
Dobutamine—Hypotension—Gabapentin—epilepsy syndrome	0.000263	0.00251	CcSEcCtD
Dobutamine—Nausea—Carbamazepine—epilepsy syndrome	0.000263	0.00251	CcSEcCtD
Dobutamine—Palpitations—Topiramate—epilepsy syndrome	0.000256	0.00245	CcSEcCtD
Dobutamine—CA2—brain—epilepsy syndrome	0.000254	0.0102	CbGeAlD
Dobutamine—Nausea—Lamotrigine—epilepsy syndrome	0.000254	0.00242	CcSEcCtD
Dobutamine—Dyspnoea—Gabapentin—epilepsy syndrome	0.000251	0.0024	CcSEcCtD
Dobutamine—Chest pain—Topiramate—epilepsy syndrome	0.000247	0.00236	CcSEcCtD
Dobutamine—Pruritus—Valproic Acid—epilepsy syndrome	0.00024	0.00229	CcSEcCtD
Dobutamine—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000232	0.00221	CcSEcCtD
Dobutamine—Tachycardia—Topiramate—epilepsy syndrome	0.000231	0.00221	CcSEcCtD
Dobutamine—Labetalol—CYP2D6—epilepsy syndrome	0.000223	0.0893	CrCbGaD
Dobutamine—Hypotension—Topiramate—epilepsy syndrome	0.000221	0.00211	CcSEcCtD
Dobutamine—Pruritus—Pregabalin—epilepsy syndrome	0.000217	0.00207	CcSEcCtD
Dobutamine—Headache—Valproic Acid—epilepsy syndrome	0.000213	0.00203	CcSEcCtD
Dobutamine—Dyspnoea—Topiramate—epilepsy syndrome	0.000211	0.00202	CcSEcCtD
Dobutamine—Nausea—Valproic Acid—epilepsy syndrome	0.000202	0.00193	CcSEcCtD
Dobutamine—Dopamine—SLC6A4—epilepsy syndrome	0.000201	0.0805	CrCbGaD
Dobutamine—Pruritus—Gabapentin—epilepsy syndrome	0.000199	0.0019	CcSEcCtD
Dobutamine—Headache—Pregabalin—epilepsy syndrome	0.000192	0.00184	CcSEcCtD
Dobutamine—Dopamine—CYP2C19—epilepsy syndrome	0.000191	0.0763	CrCbGaD
Dobutamine—Nausea—Pregabalin—epilepsy syndrome	0.000182	0.00174	CcSEcCtD
Dobutamine—Headache—Gabapentin—epilepsy syndrome	0.000176	0.00168	CcSEcCtD
Dobutamine—Pruritus—Topiramate—epilepsy syndrome	0.000168	0.0016	CcSEcCtD
Dobutamine—Nausea—Gabapentin—epilepsy syndrome	0.000167	0.0016	CcSEcCtD
Dobutamine—Headache—Topiramate—epilepsy syndrome	0.000148	0.00142	CcSEcCtD
Dobutamine—Dopamine—CYP2D6—epilepsy syndrome	0.000142	0.0566	CrCbGaD
Dobutamine—Nausea—Topiramate—epilepsy syndrome	0.000141	0.00134	CcSEcCtD
Dobutamine—ADRB2—Signaling Pathways—CCR8—epilepsy syndrome	1.71e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR9—epilepsy syndrome	1.71e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.71e-05	0.000143	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DUSP4—epilepsy syndrome	1.68e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SSTR2—epilepsy syndrome	1.68e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.68e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.68e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM3—epilepsy syndrome	1.68e-05	0.000141	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM4—epilepsy syndrome	1.68e-05	0.000141	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—ALB—epilepsy syndrome	1.68e-05	0.000141	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HMOX1—epilepsy syndrome	1.66e-05	0.000139	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.65e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SSTR2—epilepsy syndrome	1.64e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DUSP4—epilepsy syndrome	1.64e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.64e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.64e-05	0.000138	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.64e-05	0.000138	CbGpPWpGaD
Dobutamine—COMT—Metabolism—CAT—epilepsy syndrome	1.63e-05	0.000137	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GRM8—epilepsy syndrome	1.62e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PGF—epilepsy syndrome	1.62e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—SST—epilepsy syndrome	1.62e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCR2—epilepsy syndrome	1.62e-05	0.000136	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CNR1—epilepsy syndrome	1.61e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.61e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.6e-05	0.000135	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—POMC—epilepsy syndrome	1.59e-05	0.000133	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ABCB1—epilepsy syndrome	1.59e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM8—epilepsy syndrome	1.59e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PGF—epilepsy syndrome	1.59e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.59e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—SST—epilepsy syndrome	1.59e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCR2—epilepsy syndrome	1.59e-05	0.000133	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR7—epilepsy syndrome	1.57e-05	0.000132	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—PTGS2—epilepsy syndrome	1.57e-05	0.000132	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—CCL2—epilepsy syndrome	1.56e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—POMC—epilepsy syndrome	1.56e-05	0.000131	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.55e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GNAO1—epilepsy syndrome	1.55e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—OPRD1—epilepsy syndrome	1.55e-05	0.00013	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AGT—epilepsy syndrome	1.55e-05	0.00013	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.53e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.52e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.52e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—CCL2—epilepsy syndrome	1.52e-05	0.000128	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—OPRD1—epilepsy syndrome	1.52e-05	0.000127	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GNAO1—epilepsy syndrome	1.52e-05	0.000127	CbGpPWpGaD
Dobutamine—CA2—Metabolism—APOE—epilepsy syndrome	1.51e-05	0.000127	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT3—epilepsy syndrome	1.5e-05	0.000126	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CNR1—epilepsy syndrome	1.5e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.49e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CXCL12—epilepsy syndrome	1.49e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.49e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CHRM1—epilepsy syndrome	1.49e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PDYN—epilepsy syndrome	1.49e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GRM1—epilepsy syndrome	1.49e-05	0.000125	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR7—epilepsy syndrome	1.49e-05	0.000125	CbGpPWpGaD
Dobutamine—COMT—Metabolism—GPX1—epilepsy syndrome	1.48e-05	0.000124	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—PTGS2—epilepsy syndrome	1.47e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CNR1—epilepsy syndrome	1.46e-05	0.000123	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR7—epilepsy syndrome	1.46e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PLCB1—epilepsy syndrome	1.46e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PDYN—epilepsy syndrome	1.45e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR7—epilepsy syndrome	1.45e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM1—epilepsy syndrome	1.45e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CHRM1—epilepsy syndrome	1.45e-05	0.000122	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR7—epilepsy syndrome	1.43e-05	0.00012	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.42e-05	0.000119	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.4e-05	0.000117	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GFAP—epilepsy syndrome	1.4e-05	0.000117	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GAL—epilepsy syndrome	1.4e-05	0.000117	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT3—epilepsy syndrome	1.39e-05	0.000117	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HBEGF—epilepsy syndrome	1.39e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CHRM3—epilepsy syndrome	1.38e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP2—epilepsy syndrome	1.38e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GRM5—epilepsy syndrome	1.38e-05	0.000116	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CDC42—epilepsy syndrome	1.37e-05	0.000115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GAL—epilepsy syndrome	1.37e-05	0.000115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GFAP—epilepsy syndrome	1.37e-05	0.000115	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT3—epilepsy syndrome	1.36e-05	0.000114	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AVP—epilepsy syndrome	1.35e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CHRM3—epilepsy syndrome	1.35e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GRM5—epilepsy syndrome	1.35e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP2—epilepsy syndrome	1.35e-05	0.000113	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.32e-05	0.000111	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AVP—epilepsy syndrome	1.32e-05	0.000111	CbGpPWpGaD
Dobutamine—CA2—Metabolism—POMC—epilepsy syndrome	1.3e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.3e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CHRM2—epilepsy syndrome	1.3e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.3e-05	0.000109	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AGT—epilepsy syndrome	1.3e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.3e-05	0.000109	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.27e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CHRM2—epilepsy syndrome	1.27e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.27e-05	0.000107	CbGpPWpGaD
Dobutamine—COMT—Metabolism—APOE—epilepsy syndrome	1.27e-05	0.000107	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CDC42—epilepsy syndrome	1.27e-05	0.000106	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—GABBR1—epilepsy syndrome	1.26e-05	0.000106	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CDC42—epilepsy syndrome	1.24e-05	0.000104	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—GABBR1—epilepsy syndrome	1.24e-05	0.000104	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AVP—epilepsy syndrome	1.23e-05	0.000103	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HRH3—epilepsy syndrome	1.21e-05	0.000102	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AVP—epilepsy syndrome	1.2e-05	0.000101	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—OPRM1—epilepsy syndrome	1.19e-05	0.0001	CbGpPWpGaD
Dobutamine—CA2—Metabolism—ALB—epilepsy syndrome	1.19e-05	9.96e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HRH3—epilepsy syndrome	1.18e-05	9.94e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—OPRM1—epilepsy syndrome	1.17e-05	9.79e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.15e-05	9.65e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1.13e-05	9.45e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.13e-05	9.44e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.12e-05	9.44e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	1.1e-05	9.24e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.1e-05	9.24e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	1.1e-05	9.21e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.1e-05	9.21e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—POMC—epilepsy syndrome	1.09e-05	9.15e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	1.07e-05	9.01e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.07e-05	9.01e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	1.07e-05	8.96e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	1.06e-05	8.88e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	1.06e-05	8.88e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	1.06e-05	8.88e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	1.06e-05	8.88e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	1.06e-05	8.88e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	1.04e-05	8.76e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	1.04e-05	8.76e-05	CbGpPWpGaD
Dobutamine—CA2—Metabolism—PTGS2—epilepsy syndrome	1.04e-05	8.71e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	1.04e-05	8.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	1.04e-05	8.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	1.04e-05	8.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	1.04e-05	8.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	1.04e-05	8.69e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.02e-05	8.58e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	1.02e-05	8.57e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	1e-05	8.39e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—ALB—epilepsy syndrome	9.94e-06	8.34e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.86e-06	8.28e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	9.84e-06	8.26e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	9.84e-06	8.26e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	9.69e-06	8.14e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.65e-06	8.1e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	9.63e-06	8.08e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	9.63e-06	8.08e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	9.57e-06	8.03e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	9.57e-06	8.03e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SST—epilepsy syndrome	9.57e-06	8.03e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	9.49e-06	7.96e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	9.48e-06	7.96e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	9.37e-06	7.86e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	9.36e-06	7.86e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SST—epilepsy syndrome	9.36e-06	7.86e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	9.36e-06	7.86e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	9.33e-06	7.83e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	9.28e-06	7.79e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	9.16e-06	7.69e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	9.12e-06	7.66e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	9e-06	7.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	9e-06	7.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	8.99e-06	7.54e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	8.96e-06	7.52e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	8.92e-06	7.49e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	8.83e-06	7.41e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	8.83e-06	7.41e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	8.8e-06	7.39e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	8.8e-06	7.39e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	8.8e-06	7.39e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	8.79e-06	7.38e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	8.76e-06	7.35e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	8.73e-06	7.32e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—PTGS2—epilepsy syndrome	8.7e-06	7.3e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	8.64e-06	7.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	8.64e-06	7.25e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	8.62e-06	7.23e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	8.61e-06	7.23e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	8.43e-06	7.07e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	8.37e-06	7.02e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	8.21e-06	6.89e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	8.18e-06	6.87e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	8.16e-06	6.85e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	8.03e-06	6.74e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	8.02e-06	6.73e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	7.98e-06	6.7e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	7.98e-06	6.7e-05	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—AKT1—epilepsy syndrome	7.89e-06	6.62e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	7.85e-06	6.58e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	7.81e-06	6.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	7.59e-06	6.37e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	7.51e-06	6.3e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	7.49e-06	6.29e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	7.42e-06	6.23e-05	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—AKT1—epilepsy syndrome	7.37e-06	6.18e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	7.35e-06	6.17e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	7.33e-06	6.15e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	7.25e-06	6.09e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	7.1e-06	5.96e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	6.86e-06	5.76e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	6.71e-06	5.63e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	6.67e-06	5.6e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	6.65e-06	5.58e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	6.63e-06	5.57e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	6.53e-06	5.48e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	6.5e-06	5.46e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	6.49e-06	5.45e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.41e-06	5.38e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	6.34e-06	5.32e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.27e-06	5.26e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	6.2e-06	5.21e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	6.17e-06	5.18e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	6.04e-06	5.07e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	6.03e-06	5.06e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	5.9e-06	4.96e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	5.73e-06	4.81e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	5.73e-06	4.81e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	5.61e-06	4.71e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	5.61e-06	4.71e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	5.6e-06	4.7e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	5.5e-06	4.61e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	5.49e-06	4.61e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	5.38e-06	4.51e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	5.29e-06	4.44e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	5.27e-06	4.42e-05	CbGpPWpGaD
Dobutamine—CA2—Metabolism—AKT1—epilepsy syndrome	5.22e-06	4.38e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	5.18e-06	4.34e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	5.16e-06	4.33e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	4.82e-06	4.05e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	4.72e-06	3.96e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	4.72e-06	3.96e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	4.61e-06	3.87e-05	CbGpPWpGaD
Dobutamine—COMT—Metabolism—AKT1—epilepsy syndrome	4.37e-06	3.67e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	4.26e-06	3.58e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	4.17e-06	3.5e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	3.96e-06	3.32e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	3.88e-06	3.26e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	3.87e-06	3.25e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	3.8e-06	3.19e-05	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.6e-06	3.02e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	3.57e-06	3e-05	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.52e-06	2.96e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	3.49e-06	2.93e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	3.47e-06	2.91e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	3.39e-06	2.85e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	3.37e-06	2.83e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	3.3e-06	2.77e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	3.27e-06	2.75e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	3.2e-06	2.69e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	3.11e-06	2.61e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	3.04e-06	2.55e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	3.03e-06	2.54e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	2.96e-06	2.49e-05	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.93e-06	1.62e-05	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.89e-06	1.59e-05	CbGpPWpGaD
